PRESS RELEASE published on 01/12/2026 at 15:00, 8 months 5 days ago Sandoz CEO, speaking at 44th Annual J.P. Morgan Healthcare Conference, will outline plans to capitalize on unprecedented ’golden decade’ of affordable medicines opportunity Sandoz CEO to outline plans for capturing the unprecedented 'golden decade' of affordable medicines opportunity at the 44th Annual J.P. Morgan Healthcare Conference CEO Sandoz J.P. Morgan Healthcare Conference Golden Decade Affordable Medicines
BRIEF published on 12/08/2025 at 07:05, 9 months 10 days ago Sandoz Acquires Just-Evotec Biologics EU SAS to Boost Biosimilar Leadership Acquisition Healthcare Biosimilars Sandoz Group AG Continuous Manufacturing
BRIEF published on 12/08/2025 at 07:05, 9 months 10 days ago Sandoz acquiert Just-Evotec Biologics EU SAS pour renforcer son leadership dans le domaine des biosimilaires Acquisition Soins De Santé Biosimilaires Groupe Sandoz AG Fabrication Continue
PRESS RELEASE published on 12/08/2025 at 07:00, 9 months 10 days ago Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership. Expands capabilities for biosimilars with cutting-edge technology Acquisition Biosimilars Sandoz Just-Evotec Biologics EU SAS Continuous-manufacturing Technology
BRIEF published on 12/01/2025 at 07:05, 9 months 17 days ago Sandoz Launches Denosumab Biosimilars in Europe Bone Health Sandoz Denosumab Biosimilars Wyost® Jubbonti®
BRIEF published on 12/01/2025 at 07:05, 9 months 17 days ago Sandoz lance des biosimilaires de dénosumab en Europe Sandoz Wyost® Jubbonti® Biosimilaires Du Dénosumab Santé Osseuse
PRESS RELEASE published on 12/01/2025 at 07:00, 9 months 17 days ago Sandoz launches denosumab biosimilars in Europe, providing affordable treatment option for cancer-related bone disease and osteoporosis for millions of patients Sandoz launches denosumab biosimilars in Europe, providing affordable treatment options for cancer-related bone disease and osteoporosis. The European launch marks a key milestone in Sandoz's growth strategy Europe Biosimilars Cancer Osteoporosis Sandoz
BRIEF published on 11/24/2025 at 07:05, 9 months 24 days ago Sandoz Launches Afqlir® in Europe for Retinal Diseases Biosimilars Retinal Diseases Sandoz Europe Launch Afqlir®
BRIEF published on 11/24/2025 at 07:05, 9 months 24 days ago Sandoz lance Afqlir® en Europe pour le traitement des maladies rétiniennes Biosimilaires Maladies De La Rétine Sandoz Lancement En Europe Afqlir®
PRESS RELEASE published on 11/24/2025 at 07:00, 9 months 24 days ago Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases. Afqlir® matches reference medicine in efficacy, safety, and pharmacokinetics, reinforcing Sandoz commitment to patient access Retinal Diseases Sandoz Aflibercept Afqlir European Launch
Published on 09/18/2026 at 06:30, 5 hours 6 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 10 hours 41 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 11 hours 11 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 13 hours 21 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/18/2026 at 10:15, 1 hour 21 minutes ago When technology meets culture: BOE helps showcase Chinese intangible cultural heritage in London
Published on 09/18/2026 at 10:15, 1 hour 21 minutes ago Mutares has sold Cimos to the company’s management supported by investor Vero Automotive
Published on 09/18/2026 at 10:00, 1 hour 36 minutes ago HORNBACH to open new stores in Germany and across Europe
Published on 09/18/2026 at 09:55, 1 hour 40 minutes ago LAIQON: New Luxembourg SICAV launches and new equity fund established
Published on 09/18/2026 at 09:55, 1 hour 41 minutes ago Sungrow and be.storaged strengthen partnership for gigawatt-hour-scale battery storage projects
Published on 09/17/2026 at 17:40, 17 hours 56 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/17/2026 at 17:40, 17 hours 56 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany